Complete Filing Data
BIOCRYST PHARMACEUTICALS INC reported Net Income Loss of $263.86 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean BIOCRYST PHARMACEUTICALS INC did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue * | $19.1M | $12.3M | $4.5M | $6.4M | $7.2M | $1.6M | $3.7M | $1.1M | $2.3M | $1.4M | $1.0K | $86.0K | $4.5M | ||||
| Revenue * | $874.8M | $450.7M | $331.4M | $270.8M | $157.2M | $17.8M | $48.8M | $20.7M | $25.2M | $26.4M | $48.3M | $13.6M | $17.3M | $26.3M | $19.6M | $62.4M | $74.6M |
| Net Income Loss | $263.9M | -$88.9M | -$226.5M | -$247.1M | -$184.1M | -$182.8M | -$108.9M | -$101.3M | -$65.8M | -$55.1M | -$43.0M | -$45.2M | -$30.1M | -$39.1M | -$56.9M | -$33.9M | -$13.5M |
| Research And Development Expense | $166.1M | $174.6M | $216.6M | $253.3M | $208.8M | $123.0M | $107.1M | $84.9M | $67.0M | $61.0M | $72.8M | $51.8M | $41.9M | $49.2M | $57.2M | $83.9M | $73.7M |
| Operating Income Loss | $341.0M | -$2.5M | -$103.7M | -$148.4M | -$177.7M | -$174.8M | -$99.5M | -$94.2M | -$57.4M | -$48.6M | -$39.4M | -$45.8M | -$30.7M | -$33.9M | -$49.6M | -$34.4M | -$13.7M |
| Comprehensive Income Net Of Tax | $263.0M | -$89.3M | -$225.2M | -$247.3M | -$183.9M | -$182.9M | -$108.6M | -$101.3M | -$66.0M | -$55.0M | -$43.1M | -$45.3M | -$30.1M | -$39.1M | -$57.0M | -$33.7M | |
| Interest Expense | $108.2M | $99.1M | $59.3M | $14.5M | $11.9M | $9.2M | $8.6M | $6.5M | $5.2M | $5.0M | $4.8M | $4.7M | $3.8M | ||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $1.1M | -$1.0M | -$15.0K | -$36.0K | $336.0K | -$54.0K | -$231.0K | $194.0K | -$76.0K | -$134.0K | -$23.0K | -$13.0K | -$65.0K | $131.0K | -$130.0K | ||
| Selling General And Administrative Expense | $348.6M | $266.3M | $214.1M | $159.4M | $118.8M | $67.9M | $37.1M | $29.5M | $13.9M | $11.3M | $13.0M | $7.5M | $6.0M | ||||
| Other Comprehensive Income Loss Net Of Tax | $1.3M | -$151.0K | $174.0K | -$36.0K | $336.0K | -$54.0K | -$231.0K | $194.0K | -$76.0K | -$134.0K | -$23.0K | -$13.0K | -$65.0K | $131.0K | |||
| Deferred Revenue Current | $0.00 | $1.2M | $1.4M | $150.0K | $2.1M | $221.0K | $8.5M | $2.0M | $2.2M | $1.4M | $9.8M | $2.5M | |||||
| Collaborative And Other Research And Development | $13.1M | $14.4M | $39.6M | $10.6M | $14.8M | $23.0M | $19.6M | $62.1M | $51.7M | ||||||||
| Royalty Revenue | $10.5M | $9.7M | $2.4M | $3.0M | $2.6M | $3.3M | |||||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$674.0K | -$776.0K | $180.0K | $890.0K | $189.0K | $0.00 | |||||||||||
| General And Administrative Expense | $7.5M | $6.0M | $9.1M | $12.0M | $11.7M | $10.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue * | $2.2M | $2.8M | $4.6M | $3.2M | $1.7M | $1.3M | $1.1M | $894.0K | $931.0K | $3.5M | $246.0K | $236.0K | $591.0K | $297.0K | $5.9M | $1.5M | $0.00 | $0.00 | $0.00 | $0.00 | $1.4M | $1.1M | $1.3M | $15.0K | |||||||||||||||||||||||||||||||||
| Revenue * | $159.4M | $163.4M | $145.5M | $117.1M | $109.3M | $92.8M | $86.7M | $82.5M | $68.8M | $75.8M | $65.5M | $49.9M | $41.0M | $50.0M | $19.1M | $4.0M | $6.1M | $2.9M | $4.8M | $39.7M | $1.8M | $1.4M | $5.9M | $2.7M | $1.5M | $12.5M | $4.0M | $3.9M | $8.8M | $3.1M | $9.4M | $9.0M | $7.8M | $4.8M | $4.8M | $4.6M | $11.0M | $25.8M | $6.8M | $5.4M | $3.2M | $1.5M | $3.5M | $10.6M | $2.4M | $821.0K | $3.6M | $4.1M | $5.8M | $4.2M | $12.2M | $5.2M | $5.2M | $3.7M | $5.4M | $12.0M | $7.6M |
| Net Income Loss | $12.9M | $5.1M | $32.0K | -$14.0M | -$12.7M | -$35.4M | -$36.1M | -$75.3M | -$53.3M | -$42.5M | -$58.9M | -$74.2M | -$58.8M | -$43.2M | -$64.3M | -$60.5M | -$46.1M | -$38.6M | -$37.6M | -$2.6M | -$37.6M | -$37.6M | -$31.1M | -$27.4M | -$29.6M | -$18.4M | -$25.8M | -$19.5M | -$15.1M | -$16.9M | -$14.2M | -$4.5M | -$11.5M | -$16.3M | -$22.8M | -$18.1M | -$14.6M | $4.9M | -$15.2M | -$11.7M | -$8.7M | -$14.6M | -$10.1M | -$5.4M | -$8.0M | -$12.2M | -$4.5M | -$11.1M | -$9.7M | -$12.3M | -$6.1M | -$13.2M | -$14.5M | -$16.3M | -$13.0M | -$10.9M | -$10.2M |
| Research And Development Expense | $44.6M | $43.4M | $37.3M | $41.1M | $37.6M | $46.5M | $46.9M | $51.2M | $48.4M | $52.7M | $62.0M | $65.4M | $50.0M | $52.9M | $42.4M | $30.2M | $27.5M | $29.9M | $25.1M | $27.7M | $27.5M | $22.0M | $21.0M | $18.4M | $17.5M | $15.8M | $16.8M | $14.1M | $14.2M | $20.6M | $20.1M | $16.5M | $17.1M | $13.0M | $11.1M | $9.2M | $7.7M | $11.5M | $7.2M | $12.1M | $12.8M | $15.5M | $15.1M | $14.4M | $13.4M | $19.2M | $14.7M | ||||||||||
| Operating Income Loss | $29.6M | $29.8M | $21.2M | $7.7M | $8.8M | -$14.5M | -$11.9M | -$20.7M | -$28.4M | -$17.4M | -$34.7M | -$50.0M | -$44.6M | -$29.6M | -$51.4M | -$42.9M | -$38.5M | -$41.0M | -$35.1M | -$34.9M | -$29.3M | -$28.5M | -$18.3M | -$22.2M | -$13.3M | -$15.5M | -$10.7M | -$9.2M | -$12.1M | -$19.0M | -$13.2M | $5.3M | -$14.4M | -$11.6M | -$11.6M | -$7.4M | -$6.9M | -$12.1M | -$5.3M | -$8.0M | -$10.2M | -$5.0M | -$12.8M | -$14.2M | -$11.5M | -$11.0M | -$10.3M | ||||||||||
| Comprehensive Income Net Of Tax | $12.4M | $5.6M | $243.0K | -$12.3M | -$12.9M | -$35.9M | -$36.0M | -$75.2M | -$52.8M | -$42.6M | -$59.0M | -$74.2M | -$58.8M | -$43.3M | -$64.1M | -$46.1M | -$38.6M | -$37.6M | -$37.6M | -$37.5M | -$30.8M | -$29.6M | -$18.4M | -$26.0M | -$15.1M | -$16.9M | -$14.2M | -$11.6M | -$16.3M | -$22.6M | -$14.5M | $4.8M | -$15.0M | -$8.7M | -$14.6M | -$10.1M | -$8.0M | -$12.2M | -$4.5M | -$9.7M | -$12.3M | -$6.0M | -$14.5M | -$16.3M | -$13.1M | ||||||||||||
| Interest Expense | $24.7M | $24.5M | $27.3M | $28.9M | $27.4M | $24.8M | $24.0M | $23.8M | $14.1M | $13.5M | $12.9M | $2.9M | $2.9M | $3.0M | $3.0M | $3.0M | $2.7M | $2.3M | $2.2M | $2.2M | $2.1M | $2.1M | $2.1M | $1.5M | $1.4M | $1.5M | $1.2M | $1.3M | $1.3M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $288.0K | ||||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $1.2M | -$74.0K | -$313.0K | $295.0K | $46.0K | $500.0K | -$808.0K | -$275.0K | -$69.0K | -$1.0K | -$3.0K | $1.0K | $6.0K | -$11.0K | -$25.0K | $19.0K | $130.0K | $208.0K | $42.0K | $24.0K | -$233.0K | -$2.0K | -$12.0K | $9.0K | -$24.0K | -$2.0K | $254.0K | $91.0K | -$102.0K | $140.0K | -$1.0K | $1.0K | -$2.0K | -$4.0K | -$9.0K | -$12.0K | -$9.0K | $9.0K | -$42.0K | $9.0K | -$24.0K | ||||||||||||||||
| Selling General And Administrative Expense | $83.0M | $87.4M | $82.5M | $65.1M | $61.2M | $59.5M | $50.6M | $51.0M | $47.9M | $36.9M | $38.0M | $34.3M | $35.0M | $26.3M | $22.1M | $17.2M | $13.9M | $15.9M | $11.7M | $8.7M | $6.2M | $7.9M | $9.5M | $7.6M | $3.3M | $2.8M | $3.1M | $2.8M | $2.7M | $3.2M | $2.7M | $3.5M | $4.1M | ||||||||||||||||||||||||
| Other Comprehensive Income Loss Net Of Tax | -$566.0K | $110.0K | $105.0K | $559.0K | -$113.0K | -$171.0K | $9.0K | $27.0K | -$95.0K | $179.0K | $6.0K | -$11.0K | -$25.0K | $19.0K | $130.0K | $208.0K | $42.0K | $24.0K | -$233.0K | ||||||||||||||||||||||||||||||||||||||
| Deferred Revenue Current | $522.0K | $1.8M | $1.2M | $1.6M | $1.5M | $1.5M | $602.0K | $551.0K | $405.0K | $432.0K | $715.0K | $1.1M | $221.0K | $221.0K | $221.0K | $200.0K | $300.0K | $7.3M | $8.7M | $1.7M | $1.9M | $2.3M | $2.1M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.3M | $4.1M | $2.4M | $3.4M | $3.3M | ||||||||||||||||||||||
| Collaborative And Other Research And Development | $6.8M | $2.6M | $3.1M | $4.3M | $4.2M | $2.9M | $5.2M | $25.7M | $4.8M | $3.2M | $1.3M | $1.6M | $2.4M | $711.0K | $1.6M | $2.9M | $4.2M | $12.2M | $5.2M | $3.7M | $5.4M | $12.0M | $7.6M | ||||||||||||||||||||||||||||||||||
| Royalty Revenue | $442.0K | $489.0K | $6.3M | $3.5M | $629.0K | $1.9M | $126.0K | $132.0K | $1.5M | $5.0K | $125.0K | $1.8M | $8.0K | $110.0K | $1.9M | $2.8M | |||||||||||||||||||||||||||||||||||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$523.0K | $702.0K | $366.0K | $563.0K | -$140.0K | -$253.0K | -$185.0K | $59.0K | $59.0K | $695.0K | $104.0K | $78.0K | $28.0K | -$92.0K | $178.0K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||||||||
| General And Administrative Expense | $2.7M | $3.5M | $4.1M | $1.8M | $2.0M | $1.6M | $1.6M | $1.4M | $1.6M | $1.6M | $1.6M | $1.7M | $3.0M | $3.5M | $3.5M | $3.8M | $3.2M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$119.2M | -$475.9M | -$455.5M | -$294.6M | -$107.0M | -$19.3M | $38.3M | $49.2M | $83.8M | $1.6M | $47.7M | $75.6M | -$1.1M | -$454.0K | $14.8M | $65.5M | $86.3M | $46.4M |
| Cash And Cash Equivalents At Carrying Value | $89.7M | $104.7M | $110.6M | $304.8M | $504.4M | $272.1M | $114.2M | $26.7M | $50.3M | $22.1M | $28.9M | $54.5M | $21.2M | $20.9M | $16.4M | $13.6M | $41.1M | $22.3M |
| Common Stock Value | $2.1M | $2.1M | $2.1M | $1.9M | $1.8M | $1.8M | $1.5M | $1.1M | $984.0K | $738.0K | $734.0K | $720.0K | $591.0K | $509.0K | $457.0K | $450.0K | ||
| Restricted Cash And Cash Equivalents At Carrying Value | $201.0K | $210.0K | $1.8M | $1.5M | $3.3M | $2.2M | $1.6M | $1.5M | $3.3M | $1.5M | $1.6M | $150.0K | $151.0K | $308.0K | $625.0K | $625.0K | ||
| Retained Earnings Accumulated Deficit | -$1.51B | -$1.77B | -$1.68B | -$1.45B | -$1.21B | -$1.02B | -$840.6M | -$732.0M | -$631.8M | -$566.1M | -$510.9M | -$467.9M | -$422.7M | -$392.6M | -$353.5M | -$296.6M | ||
| Property Plant And Equipment Net | $8.8M | $7.8M | $7.9M | $8.6M | $8.7M | $7.1M | $7.3M | $9.1M | $9.5M | $9.9M | $5.1M | $207.0K | $306.0K | $583.0K | $1.1M | $1.9M | ||
| Prepaid Expense And Other Assets Current | $17.2M | $13.8M | $19.5M | $12.6M | $10.0M | $5.5M | $4.4M | $2.4M | $1.4M | $1.4M | $2.7M | $6.2M | $1.7M | $1.1M | $378.0K | $1.0M | ||
| Other Assets Noncurrent | $5.7M | $5.2M | $80.0K | $6.8M | $6.5M | $3.8M | $3.6M | $978.0K | $2.0M | $3.8M | $5.5M | $6.0M | $3.6M | $8.7M | $7.4M | $0.00 | ||
| Liabilities Current | $196.1M | $160.4M | $150.0M | $105.5M | $103.7M | $105.7M | $92.3M | $69.5M | $74.8M | $54.4M | $62.3M | $57.3M | $15.3M | $17.2M | $26.3M | $28.0M | ||
| Liabilities And Stockholders Equity | $514.2M | $490.4M | $517.0M | $550.0M | $588.2M | $334.7M | $175.3M | $146.8M | $178.3M | $89.8M | $122.4M | $136.9M | $48.9M | $57.4M | $82.2M | $109.4M | ||
| Assets Current | $404.3M | $422.0M | $496.0M | $516.5M | $566.1M | $323.8M | $164.3M | $114.4M | $125.4M | $67.0M | $63.8M | $89.3M | $42.1M | $42.0M | $52.9M | $87.4M | ||
| Assets | $514.2M | $490.4M | $517.0M | $550.0M | $588.2M | $334.7M | $175.3M | $146.8M | $178.3M | $89.8M | $122.4M | $136.9M | $48.9M | $57.4M | $82.2M | $109.4M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $38.0K | $921.0K | $1.3M | $26.0K | $177.0K | $3.0K | $39.0K | -$297.0K | -$243.0K | -$12.0K | -$206.0K | -$130.0K | $4.0K | $27.0K | $40.0K | $105.0K | ||
| Accrued Liabilities Current | $126.4M | $113.3M | $102.9M | $87.6M | $72.7M | $33.9M | $21.4M | $15.9M | $12.7M | $10.8M | $16.2M | $11.3M | $5.7M | $9.9M | $12.6M | $17.3M | ||
| Accounts Payable Current | $15.8M | $11.6M | $20.9M | $14.4M | $27.8M | $18.7M | $14.0M | $7.8M | $6.3M | $4.3M | $9.3M | $2.8M | $4.2M | $4.0M | $2.5M | $8.2M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $306.2M | $507.7M | $274.3M | $115.7M | $28.3M | $53.6M | $23.7M | $30.5M | ||||||||||
| Available For Sale Securities Debt Securities Current | $216.1M | $278.3M | $119.5M | $3.2M | $28.2M | $22.1M | $77.7M | $64.1M | $32.5M | $22.7M | $18.2M | $16.9M | $14.7M | $25.3M | ||||
| Inventory Net | $5.4M | $8.1M | $27.5M | $15.8M | $7.0M | $0.00 | $1.6M | $500.0K | $1.6M | $683.0K | $263.0K | $898.0K | ||||||
| Interest Payable Current | $21.7M | $14.9M | $11.8M | $12.1M | $9.0M | $6.7M | $6.0M | $3.9M | $2.0M | $1.4M | $0.00 | |||||||
| Accounts Receivable Net Current | $106.8M | $79.1M | $57.0M | $50.6M | $29.4M | $8.6M | $22.1M | $4.3M | $6.1M | $8.8M | $6.2M | |||||||
| Deferred Collaboration Expense Changes In Operating Assets And Liabilities | -$143.0K | -$74.0K | -$71.0K | $102.0K | -$59.0K | -$5.1M | -$2.3M | -$1.3M | $220.0K | -$377.0K | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$15.0M | -$6.1M | -$193.8M | -$201.5M | $233.4M | $158.6M | $87.4M | -$25.3M | $29.9M | -$6.9M | ||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Deferred Costs Current | $210.0K | $85.0K | $90.0K | $76.0K | $75.0K | $412.0K | $2.3M | $719.0K | ||||||||||
| Available For Sale Securities Debt Securities Noncurrent | $22.4M | $41.3M | $8.9M | $47.7M | $41.1M | $2.6M | $1.2M | $15.4M | ||||||||||
| Amortization Of Discount And Premium On Investments | -$2.0K | $121.0K | $117.0K | $110.0K | $157.0K | $523.0K | $570.0K | $150.0K | ||||||||||
| Cash And Cash Equivalents Period Increase Decrease | $28.2M | -$6.8M | -$25.6M | $33.4M | $273.0K | $4.4M | $2.8M | -$27.5M | $18.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$387.9M | -$421.6M | -$451.9M | -$468.6M | -$475.6M | -$476.2M | -$411.0M | -$388.7M | -$328.3M | -$242.7M | -$213.2M | -$164.2M | -$147.0M | -$106.1M | -$75.0M | $33.6M | $76.5M | $3.6M | -$41.3M | -$9.2M | $22.5M | $72.9M | $46.2M | $62.1M | $100.6M | $24.1M | $38.5M | $4.0M | $13.4M | $27.8M | $64.0M | $76.1M | $64.4M | $83.5M | $90.1M | -$5.7M | $3.4M | -$9.0M | -$2.8M | $9.8M | $15.7M | $23.2M | $26.0M | $39.3M | |||||||||
| Cash And Cash Equivalents At Carrying Value | $84.1M | $88.0M | $105.2M | $96.8M | $78.4M | $84.3M | $150.9M | $146.2M | $155.1M | $246.9M | $272.6M | $395.5M | $199.6M | $210.3M | $226.9M | $96.5M | $173.5M | $101.9M | $29.9M | $30.8M | $34.8M | $52.6M | $27.1M | $43.8M | $117.8M | $39.7M | $75.2M | $35.4M | $8.7M | $12.9M | $46.6M | $76.8M | $48.4M | $121.2M | $121.5M | $13.6M | $26.1M | $19.8M | $14.8M | $24.0M | $21.9M | $27.7M | $22.4M | $17.0M | $31.3M | $11.2M | $14.0M | ||||||
| Common Stock Value | $2.1M | $2.1M | $2.1M | $2.1M | $2.1M | $2.1M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.5M | $1.1M | $1.1M | $1.1M | $1.1M | $989.0K | $987.0K | $984.0K | $804.0K | $804.0K | $738.0K | $737.0K | $737.0K | $733.0K | $732.0K | $725.0K | $719.0K | $717.0K | $601.0K | $591.0K | $542.0K | $514.0K | $509.0K | $501.0K | $492.0K | $452.0K | ||||||||||
| Restricted Cash And Cash Equivalents At Carrying Value | $579.0K | $492.0K | $291.0K | $813.0K | $1.8M | $1.8M | $1.6M | $1.6M | $1.5M | $1.4M | $1.4M | $3.4M | $4.3M | $4.3M | $4.0M | $2.2M | $2.2M | $1.6M | $1.5M | $4.6M | $2.4M | $1.5M | $7.6M | $4.6M | $3.1M | $5.4M | $2.8M | $1.5M | $4.4M | $2.0M | $1.6M | $1.6M | $2.6M | $150.0K | $150.0K | $150.0K | $150.0K | $2.1M | $616.0K | $300.0K | $2.2M | $955.0K | $625.0K | $1.4M | |||||||||
| Retained Earnings Accumulated Deficit | -$1.75B | -$1.76B | -$1.77B | -$1.74B | -$1.73B | -$1.72B | -$1.62B | -$1.58B | -$1.51B | -$1.38B | -$1.34B | -$1.28B | -$1.19B | -$1.13B | -$1.09B | -$962.9M | -$916.8M | -$878.2M | -$838.0M | -$800.4M | -$762.8M | -$704.5M | -$674.9M | -$656.5M | -$612.3M | -$597.2M | -$580.3M | -$561.6M | -$550.0M | -$533.7M | -$492.8M | -$478.2M | -$483.1M | -$456.2M | -$447.5M | -$432.8M | -$417.3M | -$409.3M | -$397.1M | -$381.5M | -$371.8M | -$359.6M | -$340.3M | -$325.9M | |||||||||
| Property Plant And Equipment Net | $8.4M | $8.5M | $7.6M | $7.4M | $7.7M | $7.8M | $9.0M | $8.4M | $8.4M | $8.5M | $8.7M | $8.8M | $7.8M | $7.7M | $7.0M | $7.1M | $7.1M | $7.3M | $7.5M | $7.6M | $7.6M | $9.2M | $9.4M | $9.4M | $9.6M | $9.6M | $9.8M | $10.1M | $10.1M | $8.4M | $1.1M | $1.0M | $727.0K | $210.0K | $216.0K | $260.0K | $359.0K | $425.0K | $486.0K | $751.0K | $882.0K | $999.0K | $1.4M | $1.5M | |||||||||
| Prepaid Expense And Other Assets Current | $16.5M | $12.5M | $14.3M | $16.3M | $16.4M | $18.4M | $20.0M | $14.1M | $15.2M | $11.1M | $11.1M | $12.3M | $9.0M | $5.6M | $5.9M | $5.2M | $3.0M | $5.2M | $3.4M | $2.3M | $2.1M | $2.4M | $1.7M | $2.4M | $1.4M | $1.5M | $1.7M | $2.0M | $1.7M | $3.2M | $5.0M | $5.4M | $4.3M | $4.5M | $5.0M | $835.0K | $1.7M | $1.2M | $1.8M | $826.0K | $344.0K | $407.0K | $795.0K | $260.0K | |||||||||
| Other Assets Noncurrent | $4.4M | $3.6M | $4.9M | $15.6M | $12.5M | $13.0M | $11.5M | $6.9M | $7.0M | $6.8M | $7.0M | $7.2M | $5.2M | $3.8M | $3.6M | $3.6M | $3.7M | $3.8M | $4.2M | $4.3M | $5.4M | $1.4M | $841.0K | $222.0K | $2.0M | $1.9M | $2.3M | $2.2M | $1.6M | $2.7M | $5.2M | $5.7M | $6.5M | $1.3M | $2.7M | $4.5M | $5.1M | $5.7M | $6.1M | $9.1M | $8.7M | $7.7M | $7.2M | $6.7M | |||||||||
| Liabilities Current | $190.2M | $177.2M | $139.9M | $153.6M | $129.1M | $119.9M | $90.8M | $93.5M | $85.2M | $81.6M | $95.4M | $81.0M | $133.6M | $115.6M | $101.2M | $111.8M | $102.7M | $92.7M | $82.2M | $71.9M | $66.3M | $64.4M | $74.2M | $75.3M | $69.2M | $58.9M | $58.6M | $51.5M | $56.2M | $63.1M | $64.4M | $63.8M | $61.9M | $49.8M | $44.9M | $13.7M | $13.2M | $12.0M | $11.3M | $12.6M | $19.1M | $16.2M | $19.3M | $22.0M | |||||||||
| Liabilities And Stockholders Equity | $446.4M | $457.2M | $480.0M | $491.3M | $472.4M | $467.9M | $522.9M | $529.9M | $509.7M | $558.6M | $510.5M | $527.7M | $265.8M | $277.3M | $284.4M | $176.2M | $214.7M | $136.6M | $90.5M | $116.3M | $142.3M | $168.3M | $136.6M | $155.4M | $191.5M | $113.5M | $129.5M | $91.5M | $82.2M | $102.9M | $139.0M | $150.2M | $129.9M | $137.1M | $142.0M | $43.4M | $53.2M | $39.9M | $46.9M | $64.1M | $76.2M | $80.1M | $92.5M | $108.4M | |||||||||
| Assets Current | $355.7M | $398.5M | $410.0M | $427.1M | $363.5M | $447.1M | $502.5M | $511.1M | $490.9M | $509.0M | $494.9M | $511.7M | $252.7M | $265.8M | $273.8M | $162.4M | $203.8M | $125.5M | $78.8M | $103.7M | $117.6M | $128.5M | $92.7M | $104.2M | $175.4M | $92.3M | $113.5M | $64.6M | $46.1M | $50.4M | $84.5M | $107.1M | $81.4M | $135.1M | $138.3M | $35.7M | $46.8M | $33.5M | $35.4M | $46.6M | $45.1M | $52.9M | $60.4M | $79.9M | |||||||||
| Assets | $446.4M | $457.2M | $480.0M | $491.3M | $472.4M | $467.9M | $522.9M | $529.9M | $509.7M | $558.6M | $510.5M | $527.7M | $265.8M | $277.3M | $284.4M | $176.2M | $214.7M | $136.6M | $90.5M | $116.3M | $142.3M | $168.3M | $136.6M | $155.4M | $191.5M | $113.5M | $129.5M | $91.5M | $82.2M | $102.9M | $139.0M | $150.2M | $129.9M | $137.1M | $142.0M | $43.4M | $53.2M | $39.9M | $46.9M | $64.1M | $76.2M | $80.1M | $92.5M | $108.4M | |||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.1M | $1.6M | $1.1M | $2.3M | $557.0K | $771.0K | $800.0K | $690.0K | $585.0K | -$98.0K | $15.0K | $186.0K | $114.0K | $87.0K | $182.0K | $9.0K | $3.0K | $14.0K | $60.0K | $41.0K | -$89.0K | -$410.0K | -$452.0K | -$476.0K | -$17.0K | -$15.0K | -$3.0K | $22.0K | $46.0K | $48.0K | -$1.0K | -$92.0K | $10.0K | $2.0K | $3.0K | $2.0K | $2.0K | $6.0K | $15.0K | $40.0K | $40.0K | $49.0K | $50.0K | $92.0K | |||||||||
| Accrued Liabilities Current | $118.8M | $107.1M | $92.6M | $104.2M | $89.6M | $79.2M | $77.4M | $75.3M | $75.2M | $69.3M | $79.7M | $63.6M | $56.3M | $48.8M | $32.7M | $30.5M | $24.8M | $20.2M | $25.0M | $19.3M | $16.5M | $15.1M | $19.4M | $15.6M | $11.9M | $12.3M | $11.3M | $10.8M | $11.8M | $17.3M | $23.0M | $19.0M | $12.3M | $11.3M | $7.3M | $6.3M | $7.7M | $5.8M | $5.6M | $8.0M | $8.2M | $9.3M | $12.0M | $12.3M | |||||||||
| Accounts Payable Current | $5.6M | $8.6M | $10.0M | $13.5M | $7.8M | $11.9M | $10.6M | $13.9M | $6.3M | $8.6M | $12.0M | $13.9M | $19.7M | $10.1M | $13.5M | $11.6M | $9.4M | $10.1M | $10.1M | $8.3M | $6.9M | $7.9M | $4.1M | $3.6M | $4.6M | $1.8M | $5.4M | $2.8M | $5.1M | $7.7M | $3.8M | $3.8M | $5.3M | $2.3M | $2.4M | $1.4M | $1.2M | $989.0K | $1.1M | $2.3M | $3.3M | $2.1M | $3.6M | $5.0M | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $106.9M | $106.3M | $99.1M | $80.2M | $86.1M | $112.4M | $152.5M | $147.8M | $156.6M | $248.3M | $274.0M | $398.9M | $203.9M | $214.7M | $230.9M | $98.7M | $175.7M | $103.4M | $31.5M | $35.4M | $37.2M | $54.1M | $34.7M | $48.4M | $120.9M | $45.1M | $78.0M | ||||||||||||||||||||||||||
| Available For Sale Securities Debt Securities Current | $233.2M | $193.6M | $252.2M | $246.7M | $264.5M | $243.0M | $180.0M | $144.9M | $48.0M | $0.00 | $8.1M | $13.5M | $46.8M | $15.9M | $11.2M | $38.5M | $61.4M | $72.8M | $67.7M | $53.6M | $47.5M | $43.8M | $41.0M | $23.5M | $17.4M | $27.1M | $22.9M | $23.7M | $17.6M | $19.2M | $6.0M | $10.6M | $17.8M | $16.5M | $9.4M | $13.5M | $17.1M | $13.0M | $21.6M | $40.6M | $40.3M | ||||||||||||
| Inventory Net | $5.2M | $5.0M | $6.9M | $7.6M | $4.5M | $29.8M | $28.7M | $29.6M | $27.0M | $27.5M | $27.0M | $23.4M | $16.1M | $13.7M | $9.8M | $5.1M | $6.2M | $5.2M | $1.8M | $1.0M | $600.0K | $821.0K | $221.0K | $7.0K | $1.3M | $655.0K | $2.2M | $1.9M | $1.9M | $1.3M | $1.2M | $263.0K | $263.0K | $263.0K | $898.0K | $898.0K | |||||||||||||||||
| Interest Payable Current | $25.6M | $25.2M | $23.5M | $19.3M | $17.8M | $16.4M | $13.4M | $14.7M | $13.4M | $10.4M | $14.8M | $13.5M | $10.7M | $11.6M | $10.3M | $7.6M | $9.2M | $8.0M | $5.5M | $4.5M | $7.2M | $4.8M | $3.8M | $4.6M | $2.7M | $3.7M | $3.1M | $928.0K | $3.5M | $2.5M | $350.0K | $1.3M | |||||||||||||||||||||
| Accounts Receivable Net Current | $91.3M | $91.2M | $93.4M | $72.5M | $68.8M | $60.6M | $53.6M | $57.7M | $48.6M | $42.6M | $41.5M | $36.4M | $26.2M | $27.6M | $18.4M | $5.4M | $4.0M | $5.6M | $3.6M | $3.6M | $5.0M | $3.4M | $2.3M | $5.7M | $9.0M | $3.3M | $9.6M | $6.0M | $2.2M | ||||||||||||||||||||||||
| Deferred Collaboration Expense Changes In Operating Assets And Liabilities | -$18.0K | -$19.0K | -$14.0K | -$15.0K | -$95.0K | -$2.0M | -$830.0K | ||||||||||||||||||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $558.0K | -$26.3M | -$149.6M | -$108.9M | -$43.4M | -$12.3M | $8.9M | -$5.2M | $54.3M | ||||||||||||||||||||||||||||||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||
| Deferred Costs Current | $9.0K | $9.0K | $8.0K | $12.0K | $152.0K | $218.0K | $79.0K | $82.0K | $98.0K | $89.0K | $90.0K | $88.0K | $101.0K | $76.0K | $76.0K | $75.0K | $75.0K | $73.0K | $73.0K | $418.0K | $404.0K | $519.0K | $452.0K | $753.0K | $751.0K | ||||||||||||||||||||||||||||
| Available For Sale Securities Debt Securities Noncurrent | $3.0M | $0.00 | $741.0K | $11.7M | $29.2M | $33.7M | $41.6M | $4.5M | $9.6M | $3.8M | $14.4M | $24.2M | $41.1M | $47.8M | $36.1M | $41.1M | $302.0K | $602.0K | $2.7M | $680.0K | $2.5M | $16.4M | $16.4M | $13.0M | $11.8M | ||||||||||||||||||||||||||||
| Amortization Of Discount And Premium On Investments | -$1.4M | $30.0K | $14.0K | $4.0K | -$62.0K | $76.0K | $18.0K | $233.0K | |||||||||||||||||||||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | $53.1M | -$16.0M | -$6.2M | -$7.6M | -$6.1M | $11.2M | $17.7M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | -$349.9M | -$5.8M | $32.5M | $88.0M | $359.7M | $300.6M | $99.1M | $62.5M | $135.7M | $23.3M | $5.5M | $111.9M | $30.3M | $17.0M | $23.8M | $831.0K | $47.9M |
| Investing Cash Flow * | -$13.7M | $52.6M | -$131.5M | -$128.2M | $15.8M | -$6.9M | $77.9M | $4.8M | -$64.6M | $23.3M | -$18.0M | -$40.0M | -$3.5M | $24.9M | $11.3M | $221.0K | -$12.9M |
| Operating Cash Flow * | $347.4M | -$52.0M | -$95.1M | -$161.9M | -$142.2M | -$135.1M | -$89.6M | -$92.6M | -$41.1M | -$53.4M | -$13.1M | -$38.6M | -$26.5M | -$37.4M | -$32.3M | -$28.6M | -$16.2M |
| Share Based Compensation | $85.1M | $65.4M | $55.6M | $44.7M | $34.6M | $14.8M | $17.7M | $9.4M | $12.6M | $8.5M | $9.7M | $10.2M | $4.4M | $4.2M | $4.8M | $6.3M | $5.5M |
| Proceeds From Sale And Maturity Of Available For Sale Securities | $256.6M | $320.5M | $385.1M | $117.4M | $28.2M | $43.5M | $81.3M | $67.7M | $43.5M | $42.7M | $42.4M | $34.0M | $20.3M | $40.8M | $56.9M | $56.5M | $42.4M |
| Increase Decrease In Receivables | $36.8M | $22.7M | $6.1M | $21.5M | $20.8M | -$13.9M | $17.9M | -$1.8M | -$2.7M | $2.5M | -$3.2M | $7.4M | -$2.4M | -$1.3M | -$24.4M | -$3.5M | $21.7M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $7.8M | -$2.0M | $6.8M | $2.6M | $7.2M | $2.1M | $1.4M | $866.0K | -$951.0K | -$3.7M | -$637.0K | $2.1M | $620.0K | $623.0K | -$626.0K | -$51.0K | -$81.0K |
| Payments To Acquire Productive Assets | $2.5M | $1.1M | $2.2M | $1.4M | $2.4M | $514.0K | $343.0K | $366.0K | $328.0K | $5.3M | $5.1M | $106.0K | $30.0K | $113.0K | $55.0K | $325.0K | $604.0K |
| Depreciation Depletion And Amortization | $1.4M | $1.2M | $1.7M | $1.4M | $777.0K | $748.0K | $724.0K | $770.0K | $704.0K | $483.0K | $180.0K | $177.0K | $304.0K | $628.0K | $886.0K | $2.3M | |
| Payments To Acquire Available For Sale Securities Debt | $262.2M | $266.8M | $514.4M | $244.3M | $10.0M | $49.8M | $3.0M | $62.6M | $107.8M | $14.1M | $53.8M | $73.9M | $24.0M | $16.2M | $45.5M | $55.9M | |
| Proceeds From Stock Options Exercised | $15.0M | $15.8M | $2.4M | $1.2M | $2.9M | $1.6M | $317.0K | $5.5M | $5.3M | $1.3M | $534.0K | $278.0K | $553.0K | $2.1M | |||
| Increase Decrease In Inventories | $1.6M | $4.2M | $1.5M | $12.4M | $8.8M | $7.0M | -$1.6M | $1.6M | -$500.0K | -$1.1M | $929.0K | $683.0K | -$263.0K | -$635.0K | -$5.4M | $6.3M | |
| Increase Decrease In Accounts Payable | $57.8M | $14.8M | $12.5M | -$22.4M | $39.4M | $17.4M | $11.7M | $4.5M | $3.8M | -$10.5M | $13.7M | $4.7M | -$2.0M | ||||
| Increase Decrease In Interest Payable Net | $0.00 | $0.00 | $4.2M | $6.8M | $3.1M | -$247.0K | $3.1M | $2.2M | $717.0K | $2.2M | |||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $0.00 | $50.0M | $93.3M | $58.5M | $53.4M | $134.0M | $106.6M | $23.6M | $17.8M | $1.0M | $45.7M | |||||
| Increase Decrease In Derivative Assets | $0.00 | $0.00 | -$632.0K | -$347.0K | -$1.0M | -$966.0K | $811.0K | -$564.0K | $5.5M | $5.3M | -$749.0K | -$4.0M | |||||
| Increase Decrease In Deferred Revenue | -$1.7M | -$1.6M | $1.2M | $4.4M | -$1.1M | -$9.6M | -$1.6M | -$2.5M | -$2.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $529.0K | -$1.0M | $5.1M | $7.4M | $2.9M | $266.0K | $20.0M | -$1.5M | $48.7M | $138.0K | $1.5M | $2.4M | $3.0M | $11.9M | $24.3M |
| Investing Cash Flow * | $27.1M | $28.8M | -$107.1M | -$38.5M | $14.7M | $10.7M | $15.9M | $15.9M | $14.1M | $2.7M | -$3.9M | -$1.0M | $2.1M | $11.5M | $7.8M |
| Operating Cash Flow * | -$27.5M | -$53.7M | -$47.5M | -$77.8M | -$61.0M | -$23.3M | -$27.0M | -$19.7M | -$8.5M | -$18.8M | -$3.7M | -$9.0M | -$11.2M | -$12.2M | -$14.3M |
| Share Based Compensation | $21.4M | $13.7M | $14.0M | $9.6M | $5.5M | $2.8M | $3.3M | $2.9M | $2.5M | $2.6M | $2.3M | $1.6M | $1.6M | $1.0M | $1.5M |
| Proceeds From Sale And Maturity Of Available For Sale Securities | $76.0M | $117.0M | $41.7M | $0.00 | $14.8M | $10.8M | $19.0M | $20.3M | $14.1M | $6.3M | $2.5M | $8.4M | $2.4M | $15.6M | $12.3M |
| Increase Decrease In Receivables | $14.0M | $3.8M | -$2.0M | $7.0M | $261.0K | -$16.5M | $709.0K | -$423.0K | $796.0K | $1.1M | -$3.9M | $1.2M | -$237.0K | $22.0K | -$4.2M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $132.0K | -$1.1M | $2.5M | $2.3M | $9.9M | $847.0K | -$1.4M | $1.0M | $284.0K | $546.0K | -$1.8M | -$892.0K | $679.0K | -$15.0K | -$329.0K |
| Payments To Acquire Productive Assets | $143.0K | $235.0K | $160.0K | $406.0K | $99.0K | $116.0K | $93.0K | $35.0K | $3.0K | $3.3M | $565.0K | $7.0K | $69.0K | $30.0K | |
| Depreciation Depletion And Amortization | $331.0K | $306.0K | $405.0K | $317.0K | $178.0K | $218.0K | $176.0K | $186.0K | $172.0K | $47.0K | $45.0K | $53.0K | $97.0K | $168.0K | |
| Payments To Acquire Available For Sale Securities Debt | $48.8M | $88.0M | $148.6M | $38.1M | $0.00 | $3.0M | $4.3M | $3.4M | $9.4M | $3.7M | |||||
| Proceeds From Stock Options Exercised | $5.1M | $7.4M | $2.9M | $266.0K | $563.0K | $268.0K | $950.0K | $7.0K | $326.0K | $3.8M | $102.0K | $509.0K | $140.0K | ||
| Increase Decrease In Inventories | $870.0K | $1.2M | -$131.0K | $354.0K | -$1.9M | $0.00 | -$1.0M | $7.0K | $155.0K | $337.0K | $527.0K | ||||
| Increase Decrease In Accounts Payable | -$47.1M | -$44.6M | -$27.2M | -$22.9M | -$7.4M | -$5.1M | -$1.4M | $152.0K | $1.6M | -$541.0K | $3.4M | ||||
| Increase Decrease In Interest Payable Net | $0.00 | $1.9M | $1.5M | $1.5M | $1.4M | $1.3M | $1.2M | $1.2M | $685.0K | $1.1M | $1.1M | $257.0K | |||
| Proceeds From Issuance Of Common Stock | $47.8M | $1.2M | $360.0K | $11.7M | |||||||||||
| Increase Decrease In Derivative Assets | $0.00 | -$20.0K | $406.0K | -$1.8M | -$1.5M | -$2.8M | $464.0K | -$1.5M | $2.0M | ||||||
| Increase Decrease In Deferred Revenue | -$449.0K | -$480.0K | -$359.0K | -$296.0K | -$152.0K | -$7.7M | -$624.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $1.21 | -$0.43 | -$1.18 | -$1.33 | -$1.03 | -$1.09 | -$940.00 | -$0.98 | -$0.78 | -$0.75 | -$0.59 | -$0.68 | -$0.55 | -$0.79 | -$1.26 | -$0.76 | -$0.35 |
| Weighted Average Number Of Diluted Shares Outstanding | 218.6M | 206.7M | 192.2M | 185.9M | 179.1M | 167.3M | 115.6M | 103.2M | 84.5M | 73.7M | 72.9M | 66.8M | 55.2M | ||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0K | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |
| Common Stock Shares Outstanding | 213.1M | 208.5M | 205.8M | 187.9M | 184.4M | 176.9M | 154.1M | 110.1M | 98.4M | 73.8M | 73.4M | 72.0M | 59.1M | 50.9M | 45.7M | 45.0M | |
| Common Stock Shares Issued | 213.1M | 208.5M | 205.8M | 187.9M | 184.4M | 176.9M | 154.1M | 110.1M | 98.4M | 73.8M | 73.4M | 72.0M | 59.1M | 50.9M | 45.7M | 45.0M | |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |
| Common Stock Shares Authorized | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 95.0M | 95.0M | 95.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Earnings Per Share Basic | $1.26 | $-0.43 | $-1.18 | $-1.33 | $-1.03 | $-1.09 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.06 | $0.02 | $0.00 | -$0.07 | -$0.06 | -$0.17 | -$0.19 | -$0.40 | -$0.28 | -$0.23 | -$0.32 | -$0.40 | -$0.33 | -$0.24 | -$0.36 | -$0.34 | -$260.00 | -$240.00 | -$0.24 | -$0.02 | -$0.34 | -$0.34 | -$0.28 | -$0.25 | -$0.28 | -$0.19 | -$0.26 | -$0.20 | -$0.18 | -$0.21 | -$0.19 | -$0.06 | -$0.16 | -$0.22 | -$0.31 | -$0.20 | $0.06 | -$0.21 | -$0.16 | -$0.12 | -$0.23 | -$0.17 | -$0.09 | -$0.14 | -$0.23 | -$0.09 | -$0.22 | -$0.19 | -$0.25 | -$0.13 | -$0.29 | -$0.32 | -$0.36 | -$0.29 | -$0.24 | -$0.23 | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 219.9M | 219.9M | 215.3M | 206.9M | 206.4M | 206.1M | 189.6M | 189.1M | 188.5M | 186.2M | 185.6M | 184.9M | 179.1M | 178.1M | 177.3M | 176.5K | 161.6K | 154.2M | 110.4M | 110.3M | 110.2M | 105.4M | 98.8M | 98.6M | 83.6M | 80.4M | 75.2M | 73.7M | 73.7M | 73.6M | 73.3M | 76.8M | 72.3M | 71.8M | 63.6M | |||||||||||||||||||||||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0K | 5.0K | 5.0K | 5.0K | 5.0K | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0K | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0K | 5.0K | ||||||||||||||||
| Common Stock Shares Outstanding | 210.5M | 209.9M | 209.2M | 207.1M | 206.6M | 206.3M | 189.8M | 189.5M | 188.9M | 186.4M | 185.9M | 185.6M | 179.8M | 178.7M | 177.7M | 176.6M | 176.4M | 154.2M | 110.4M | 110.4M | 110.3M | 109.6M | 98.9M | 98.7M | 98.4M | 80.4M | 80.4M | 73.8M | 73.7M | 73.7M | 73.3M | 73.2M | 72.5M | 71.9M | 71.7M | 60.1M | 59.1M | 54.2M | 51.4M | 50.9M | 50.1M | 49.2M | 45.2K | 45.2K | ||||||||||||||||
| Common Stock Shares Issued | 210.5M | 209.9M | 209.2M | 207.1M | 206.6M | 206.3M | 189.8M | 189.5M | 188.9M | 186.4M | 185.9M | 185.6M | 179.8M | 178.7M | 177.7M | 176.6M | 176.4M | 154.2M | 110.4M | 110.4M | 110.3M | 109.6M | 98.9M | 98.7M | 98.4M | 80.4M | 80.4M | 73.8M | 73.7M | 73.7M | 73.3M | 73.2M | 72.5M | 71.9M | 71.7M | 60.1M | 59.1M | 54.2M | 51.4M | 50.9M | 50.1M | 49.2M | 45.2K | 45.2K | ||||||||||||||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||||||||||||||||
| Common Stock Shares Authorized | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 95.0M | 95.0M | 95.0M | 95.0M | 95.0M | 95.0M | 95.0M | 95.0K | 95.0K | ||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Earnings Per Share Basic | $0.06 | $0.02 | $0.00 | $-0.07 | $-0.06 | $-0.17 | $-0.19 | $-0.40 | $-0.28 | $-0.23 | $-0.32 | $-0.40 | $-0.33 | $-0.24 | $-0.36 | $-0.22 | $0.07 | $-0.23 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Costs And Expenses | $533.8M | $453.3M | $435.1M | $419.3M | $334.9M | $192.6M | $148.3M | $114.9M | $82.6M | $75.0M | $87.7M | $59.4M | $48.0M | $60.2M | $69.2M | $96.7M | $88.3M |
| Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments | -$152.0K | -$641.0K | -$1.0M | -$2.0M | -$695.0K | -$965.0K | $517.0K | -$108.0K | -$821.0K | -$843.0K | $1.1M | $5.5M | $5.3M | -$749.0K | -$4.0M | ||
| Interest And Other Income | $10.7M | $14.7M | $15.8M | $5.1M | $1.9M | $2.3M | $1.0M | $793.0K | $535.0K | $93.0K | $93.0K | $222.0K | $413.0K | $504.0K | $286.0K | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $85.1M | $65.4M | $55.6M | $44.7M | $34.6M | $14.8M | $17.7M | $9.4M | $12.6M | $8.5M | $9.7M | $10.2M | $4.4M | $4.2M | $4.8M | $6.3M | $5.5M |
| Stock Issued During Period Value Stock Options Exercised | $7.9M | $2.3M | $6.1M | $11.9M | $13.7M | $1.8M | $835.0K | $2.5M | $1.2M | -$12.0K | $5.1M | $5.0M | $1.3M | $539.0K | $278.0K | $552.0K | $2.1M |
| Amortization Of Financing Costs | $2.4M | $1.3M | $885.0K | $876.0K | $558.0K | $439.0K | $439.0K | $439.0K | $439.0K | $356.0K | |||||||
| Royalty Expense | $126.0K | $375.0K | $471.0K | $560.0K | $402.0K | $528.0K | $121.0K | $98.0K | $132.0K | ||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $2.3M | $1.9M | $2.6M | $2.9M | $2.0M | $632.0K | $404.0K | $351.0K | $345.0K | $329.0K | $355.0K | $310.0K | $124.0K | $321.0K | $300.0K | $283.0K | $194.0K |
| Additional Paid In Capital | $1.38B | $1.29B | $1.22B | $1.16B | $1.10B | $1.00B | $877.3M | $780.4M | $714.9M | $566.9M | $558.1M | $542.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Costs And Expenses | $129.8M | $133.6M | $124.3M | $109.4M | $100.6M | $107.2M | $98.7M | $103.2M | $97.2M | $93.3M | $100.3M | $99.9M | $85.6M | $79.5M | $70.4M | $49.0M | $41.4M | $45.8M | $36.9M | $36.4M | $35.2M | $29.9M | $30.7M | $26.2M | $22.1M | $18.6M | $20.1M | $17.0M | $16.9M | $23.9M | $24.1M | $20.5M | $21.3M | $14.8M | $13.1M | $10.8M | $9.3M | $13.0M | $8.9M | $13.8M | $14.4M | $17.2M | $18.1M | $18.0M | $16.9M | $23.0M | $17.9M |
| Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments | $35.0K | -$63.0K | $1.0K | $98.0K | -$84.0K | -$51.0K | -$737.0K | $301.0K | -$229.0K | -$538.0K | $132.0K | -$177.0K | -$111.0K | -$134.0K | -$29.0K | -$12.0K | $63.0K | -$20.0K | $148.0K | -$223.0K | $406.0K | $631.0K | $1.5M | -$1.8M | $130.0K | $521.0K | -$1.5M | -$931.0K | -$2.9M | -$2.8M | -$352.0K | $749.0K | $464.0K | $4.1M | -$1.8M | -$1.5M | $97.0K | $1.1M | $2.0M | -$572.0K | -$997.0K | $38.0K | -$586.0K | -$998.0K | -$1.3M | ||
| Interest And Other Income | $2.2M | $2.5M | $3.0M | $3.6M | $3.6M | $4.0M | $4.2M | $3.8M | $3.4M | $2.8M | $6.4M | $402.0K | $547.0K | $596.0K | $611.0K | $493.0K | $462.0K | $225.0K | $203.0K | $109.0K | $109.0K | $147.0K | $439.0K | $134.0K | $116.0K | $117.0K | $14.0K | $19.0K | $17.0K | $18.0K | $21.0K | $33.0K | $54.0K | $57.0K | $71.0K | $92.0K | $136.0K | $102.0K | $126.0K | $137.0K | |||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $18.6M | $21.3M | $21.4M | $17.2M | $13.2M | $13.7M | $12.3M | $12.8M | $14.0M | $10.0M | $9.9M | $9.6M | $13.0M | $7.6M | $5.5M | $2.9M | $3.3M | $2.8M | $5.3M | $5.4M | $3.3M | $2.1M | $2.1M | $2.9M | |||||||||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $1.6M | $3.4M | $1.2M | $1.4M | $264.0K | $552.0K | $456.0K | $1.7M | $3.5M | $1.9M | $145.0K | $5.9M | $3.5M | $4.6M | $2.2M | $366.0K | $532.0K | $266.0K | $414.0K | $343.0K | $595.0K | $468.0K | $81.0K | ||||||||||||||||||||||||
| Amortization Of Financing Costs | $381.0K | $341.0K | $341.0K | $341.0K | $341.0K | $255.0K | $222.0K | $223.0K | $232.0K | $219.0K | $220.0K | $220.0K | $116.0K | $110.0K | $110.0K | $110.0K | $110.0K | $110.0K | $110.0K | $110.0K | $110.0K | $110.0K | $110.0K | $110.0K | $110.0K | $110.0K | $110.0K | $31.0K | |||||||||||||||||||
| Royalty Expense | $9.0K | $0.00 | $69.0K | $18.0K | $26.0K | $87.0K | $18.0K | $243.0K | $140.0K | $115.0K | $22.0K | $294.0K | $143.0K | $27.0K | $77.0K | $5.0K | $442.0K | $60.0K | $5.0K | $73.0K | $4.0K | $77.0K | $114.0K | ||||||||||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $1.1M | $1.2M | $723.0K | $1.1M | $1.0M | $1.6M | $1.4M | $1.5M | $1.2M | $7.6M | $723.0K | $366.0K | $266.0K | $184.0K | $220.0K | $164.0K | $187.0K | ||||||||||||||||||||||||||||||
| Additional Paid In Capital | $1.36B | $1.34B | $1.31B | $1.27B | $1.25B | $1.24B | $1.21B | $1.19B | $1.18B | $1.14B | $1.13B | $1.12B | $1.04B | $1.02B | $1.01B | $994.8M | $991.6M | $880.3M | $795.6M | $790.1M | $784.3M | $776.7M | $720.6M | $718.0M | $712.0M | $620.5M | $618.0M | $564.8M | $562.6M | $560.8M | $556.1M | $553.6M |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.